Woo, Marcel S. http://orcid.org/0000-0002-1306-2708
Nilsson, Johanna
Therriault, Joseph
Rahmouni, Nesrine
Brinkmalm, Ann
Benedet, Andrea L.
Ashton, Nicholas J.
Macedo, Arthur C.
Servaes, Stijn
Wang, Yi-Ting
Tissot, Cécile
Arias, Jaime Fernandez
Hosseini, Seyyed Ali
Chamoun, Mira
Lussier, Firoza Z.
Karikari, Thomas K.
Stevenson, Jenna
Mayer, Christina http://orcid.org/0000-0002-4148-2822
Ferrari-Souza, João Pedro http://orcid.org/0000-0003-2183-1551
Kobayashi, Eliane
Massarweh, Gassan
Friese, Manuel A. http://orcid.org/0000-0001-6380-2420
Pascoal, Tharick A.
Gauthier, Serge
Zetterberg, Henrik
Blennow, Kaj
Rosa-Neto, Pedro
Article History
Received: 15 October 2023
Accepted: 17 November 2023
First Online: 24 November 2023
Declarations
:
: The study was approved by the MNI PET working committee and the Douglas Mental Health University Institute Research Ethics Board. Written informed consent was obtained for all participants.
: Written informed consent was obtained for all participants.
: H.Z. has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. K.B. has served as a consultant and at advisory boards for Acumen, ALZPath, BioArctic, Biogen, Eisai, Julius Clinical, Lilly, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served at data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for Biogen, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. All the other authors declare no competing interests.